about
Rotaviruses: from pathogenesis to vaccinationAntibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.Enteric campylobacteria and RNA viruses associated with healthy and diarrheic humans in the Chinook health region of southwestern Alberta, Canada.Development of mucosal and systemic lymphoproliferative responses and protective immunity to human group A rotaviruses in a gnotobiotic pig modelSystematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease.Study of the Ability of Bifidobacteria of Human Origin to Prevent and Treat Rotavirus Infection Using Colonic Cell and Mouse Models.Comparison of fecal indicators with pathogenic bacteria and rotavirus in groundwaterRotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces.Detection of Common, Emerging and Uncommon VP4, and VP7 Human Group A Rotavirus Genotypes from Urban Sewage Samples in Uruguay.Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence.Molecular basis of age-dependent gastric inactivation of rhesus rotavirus in the mouse.Quality of greywater treated in biochar filter and risk assessment of gastroenteritis due to household exposure during maintenance and irrigation.Virucidal effect of commercially available disinfectants on equine group A rotavirus.Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses.A modification of the quininium resin test for assessing gastric acidity.Detection and distribution of rotavirus in municipal sewage treatment plants (STPs) and surface water in Beijing.A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in In
P2860
Q24609374-E09B4EDB-0630-4F22-9123-FC16596465B3Q33781989-83B741CF-CF81-4B85-97FE-0F0EFB172FF5Q34487708-2076B594-206B-4790-8702-43074DB265D0Q35226896-E17F4D58-0E8F-47BA-8A96-F5DD9BE958C7Q35860373-E87E5739-7071-4F14-9ABB-A5135D66F6C9Q36160564-956ABB68-5C92-48ED-90AA-183A6D337A92Q36653490-AE3578C2-6098-4DE1-AF25-63ABEBCC2E76Q37152736-D72C37FD-2A1E-4B09-ABAC-F4FA6FA5514BQ38974879-6361ECDF-1A8D-4C34-B7FF-680536F97B5EQ39578213-59E19F1C-BD42-4615-BB60-4866A44F085FQ40343611-4BCC1B68-1067-4858-B1C3-28E3BDCAFD97Q40500371-0B46D6A6-02CD-43FE-B194-065A8397FD3AQ42228091-9FED8B6B-14DF-4C06-BF1A-5AAF4F6369FEQ43054231-D6BEBD55-AE03-483D-AF4F-759FA476F34EQ43967097-B48B20D9-8578-4280-86DB-0B29301CB31AQ47913809-9F140D91-7982-4ED6-A670-4F89E591A885Q54255457-75DA1BF6-D05F-4705-A1CC-8417CC9B06F9
P2860
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Minimal infective dose of rotavirus.
@ast
Minimal infective dose of rotavirus.
@en
Minimal infective dose of rotavirus.
@nl
type
label
Minimal infective dose of rotavirus.
@ast
Minimal infective dose of rotavirus.
@en
Minimal infective dose of rotavirus.
@nl
prefLabel
Minimal infective dose of rotavirus.
@ast
Minimal infective dose of rotavirus.
@en
Minimal infective dose of rotavirus.
@nl
P356
P1433
P1476
Minimal infective dose of rotavirus.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF01317483
P577
1987-01-01T00:00:00Z
P6179
1044411716